The iLet is a closed-loop delivery system that can be used in insulin-only, bihormonal, or
glucagon-only configurations. Previous studies have utilized a phone-based bionic pancreas.
The iLet consists of a touchscreen-enabled, menu-driven user interface and an onboard
microprocessor that provides a comprehensive and standalone platform, which allows the iLet
to operate independently of smartphones or other devices and without the need for internet
support during routine operation.
This is a multicenter study of adult participants with type 1 diabetes, who will manage their
diabetes with the iLet bionic pancreas compared to usual care.